Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mast Therapeutics Inc.

Division of Mast Therapeutics Inc./AIres Pharmaceuticals Inc.
www.masttherapeutics.com

Latest From Mast Therapeutics Inc.

In Hindsight, Savara Wishes It Led With Patient-Reported Secondary Endpoint For Molgradex

Orphan lung disease firm tries to sell Phase III setback in aPAP as a “successful failed study” but investors disagree, cutting Savara’s share price by three-quarters. Biotech hopes to talk with regulators after deeper dive into dataset.

Clinical Trials Drug Approval Standards

Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year

Public Company Edition: Nine more biopharma companies launched IPOs in the US in July, bringing the 2018 total to 45 first-time offerings – three more than in all of 2017. Bluebird's $632.5m offering leads recent follow-on public offerings.

Financing Business Strategies

Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus

This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.

Appointments BioPharmaceutical

Antibiotic Pipeline Profile: Targeting Delivery To Infection Site

Among the antibiotics that have garnered a qualified infectious disease product designation, a collection of late-stage products are targeted at local delivery, especially inhaled and vaginal formulations.

Infectious Diseases Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Cardiovascular
  • Alias(es)
  • BioQuest Inc.
  • Biokeys Pharmaceuticals Inc.
  • AdventRx Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mast Therapeutics Inc.
  • Savara Inc.
  • Senior Management
  • Brian M Culley, CEO
    Brandi L Roberts, SVP, CFO
    Martin R Emanuele, PhD, SVP, Dev.
    Gregory D Gorgas, SVP, Commercial
    Edwin L Parsley, DO, SVP, CMO
  • Contact Info
  • Mast Therapeutics Inc.
    Phone: (858) 552-0866
    3611 Valley Centre Dr., Ste. 500
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register